{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    25,
    26,
    27,
    28,
    29
  ],
  "modelUsed": "claude-opus-4-5",
  "studyDesignStructure": {
    "studyArms": [
      {
        "id": "arm_1",
        "name": "Active Comparator A: Diagnosis by Molecular Testing",
        "type": {
          "code": "Active Comparator Arm",
          "codeSystem": "USDM",
          "decode": "Active Comparator Arm"
        },
        "instanceType": "StudyArm",
        "description": "Diagnosis and treatment based on the results of Urine PCR testing. Patients assigned even numbers on randomization table receive treatment guided by urine PCR results using KingFisher Duo Prime, QuantStudio 6 and 7 Flex Real-Time PCR System, and QuantStudio 12k Flex Real-Time PCR System."
      },
      {
        "id": "arm_2",
        "name": "Active Comparator B: Diagnosis by Conventional Testing",
        "type": {
          "code": "Active Comparator Arm",
          "codeSystem": "USDM",
          "decode": "Active Comparator Arm"
        },
        "instanceType": "StudyArm",
        "description": "Diagnosis and treatment based on the results of Urine Culture and Sensitivity (C&S) testing. Patients assigned odd numbers on randomization table receive treatment guided by urine C&S results."
      }
    ],
    "studyCells": [
      {
        "id": "cell_1",
        "armId": "arm_1",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_2",
        "armId": "arm_1",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_3",
        "armId": "arm_1",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_4",
        "armId": "arm_1",
        "epochId": "epoch_4",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_5",
        "armId": "arm_2",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_6",
        "armId": "arm_2",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_7",
        "armId": "arm_2",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_8",
        "armId": "arm_2",
        "epochId": "epoch_4",
        "elementIds": [],
        "instanceType": "StudyCell"
      }
    ],
    "studyCohorts": [
      {
        "id": "cohort_1",
        "name": "Elderly",
        "instanceType": "StudyCohort",
        "characteristic": "Patients aged 65 years or older"
      },
      {
        "id": "cohort_2",
        "name": "Male",
        "instanceType": "StudyCohort",
        "characteristic": "Male patients"
      },
      {
        "id": "cohort_3",
        "name": "Pregnant",
        "instanceType": "StudyCohort",
        "characteristic": "Pregnant patients"
      },
      {
        "id": "cohort_4",
        "name": "Recurrent UTI",
        "instanceType": "StudyCohort",
        "characteristic": "Patients with multiple occurrence (≥3) of uncomplicated or complicated UTI in past 12 months"
      },
      {
        "id": "cohort_5",
        "name": "Underlying co-morbidities",
        "instanceType": "StudyCohort",
        "characteristic": "Patients with metabolic disorder (e.g. diabetes), immunosuppression, or impaired renal function (e.g. chronic kidney disease)"
      },
      {
        "id": "cohort_6",
        "name": "Functional and anatomic abnormalities",
        "instanceType": "StudyCohort",
        "characteristic": "Patients with known functional and anatomic abnormalities of the urinary tract (e.g. stones, stents, recent instrumentation, indwelling catheters, neurogenic bladder, or polycystic kidney disease)"
      },
      {
        "id": "cohort_7",
        "name": "Persistent infection",
        "instanceType": "StudyCohort",
        "characteristic": "Patients with persistent infection after primary antibiotic therapy"
      }
    ],
    "summary": {
      "armCount": 2,
      "cellCount": 8,
      "cohortCount": 7
    },
    "studyDesign": {
      "id": "sd_1",
      "name": "Study Design",
      "instanceType": "InterventionalStudyDesign",
      "trialIntentTypes": [
        {
          "code": "Diagnostic",
          "codeSystem": "USDM",
          "decode": "Diagnostic"
        }
      ],
      "trialType": {
        "code": "Interventional",
        "codeSystem": "USDM",
        "decode": "Interventional"
      },
      "blindingSchema": {
        "code": "Open Label",
        "codeSystem": "USDM",
        "decode": "Open Label"
      },
      "randomizationType": {
        "code": "Randomized",
        "codeSystem": "USDM",
        "decode": "Randomized"
      },
      "allocationRatio": {
        "ratio": "1:1"
      },
      "controlType": {
        "code": "Active Control",
        "codeSystem": "USDM",
        "decode": "Active Control"
      },
      "armIds": [
        "arm_1",
        "arm_2"
      ],
      "cohortIds": [
        "cohort_1",
        "cohort_2",
        "cohort_3",
        "cohort_4",
        "cohort_5",
        "cohort_6",
        "cohort_7"
      ],
      "therapeuticAreas": [
        "Urology",
        "Infectious Disease"
      ]
    }
  },
  "rawResponse": {
    "studyDesign": {
      "type": "Interventional",
      "trialIntentTypes": [
        "Diagnostic"
      ],
      "blinding": {
        "schema": "Open Label",
        "maskedRoles": []
      },
      "randomization": {
        "type": "Randomized",
        "allocationRatio": "1:1",
        "stratificationFactors": []
      },
      "controlType": "Active Control",
      "therapeuticAreas": [
        "Urology",
        "Infectious Disease"
      ]
    },
    "arms": [
      {
        "name": "Active Comparator A: Diagnosis by Molecular Testing",
        "type": "Active Comparator",
        "description": "Diagnosis and treatment based on the results of Urine PCR testing. Patients assigned even numbers on randomization table receive treatment guided by urine PCR results using KingFisher Duo Prime, QuantStudio 6 and 7 Flex Real-Time PCR System, and QuantStudio 12k Flex Real-Time PCR System."
      },
      {
        "name": "Active Comparator B: Diagnosis by Conventional Testing",
        "type": "Active Comparator",
        "description": "Diagnosis and treatment based on the results of Urine Culture and Sensitivity (C&S) testing. Patients assigned odd numbers on randomization table receive treatment guided by urine C&S results."
      }
    ],
    "cohorts": [
      {
        "name": "Elderly",
        "characteristic": "Patients aged 65 years or older"
      },
      {
        "name": "Male",
        "characteristic": "Male patients"
      },
      {
        "name": "Pregnant",
        "characteristic": "Pregnant patients"
      },
      {
        "name": "Recurrent UTI",
        "characteristic": "Patients with multiple occurrence (≥3) of uncomplicated or complicated UTI in past 12 months"
      },
      {
        "name": "Underlying co-morbidities",
        "characteristic": "Patients with metabolic disorder (e.g. diabetes), immunosuppression, or impaired renal function (e.g. chronic kidney disease)"
      },
      {
        "name": "Functional and anatomic abnormalities",
        "characteristic": "Patients with known functional and anatomic abnormalities of the urinary tract (e.g. stones, stents, recent instrumentation, indwelling catheters, neurogenic bladder, or polycystic kidney disease)"
      },
      {
        "name": "Persistent infection",
        "characteristic": "Patients with persistent infection after primary antibiotic therapy"
      }
    ],
    "epochs": [
      {
        "name": "Pre-screening",
        "description": "Recruitment and initial contact with potential participants"
      },
      {
        "name": "Screening and Baseline",
        "description": "Visit 1 (Day 0) - Informed consent, eligibility assessment, urine sample collection, randomization"
      },
      {
        "name": "Treatment",
        "description": "Visit 2 (Day 0 + 5) - Treatment initiation within 24 hours of test results becoming available"
      },
      {
        "name": "End-of-Study",
        "description": "Visit 3 (Day 28 ± 7) - Final assessment, urine specimen collection, clinical outcome evaluation"
      }
    ]
  }
}